The HH signaling pathway in CML has been shown to undergo crosstalk with other coactivated oncogenic pathways, including the Wnt/β-catenin signaling pathway, as observed in CD34+ and c-kit+ CML progenitor cells [58]. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.